Maven Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,400
Closed -$1.4M 469
2025
Q4
$1.4M Buy
+11,400
New +$1.39M 0.03% 347
2023
Q4
Sell
-34,100
Closed -$2.56M 1032
2023
Q3
$2.56M Sell
34,100
-3,200
-9% -$246K 0.03% 330
2023
Q2
$2.87M Buy
37,300
+25,300
+211% +$2.02M 0.04% 212
2023
Q1
$996K Buy
12,000
+6,800
+131% +$563K 0.02% 467
2022
Q4
$443K Sell
5,200
-45,900
-90% -$3.63M 0.01% 603
2022
Q3
$3.15M Buy
51,100
+27,500
+117% +$1.73M 0.06% 197
2022
Q2
$1.46M Buy
23,600
+17,300
+275% +$1.07M 0.04% 279
2022
Q1
$375K Sell
6,300
-13,400
-68% -$857K 0.01% 632
2021
Q4
$1.43M Buy
19,700
+7,500
+61% +$517K 0.04% 260
2021
Q3
$852K Sell
12,200
-6,000
-33% -$422K 0.03% 498
2021
Q2
$1.25M Sell
18,200
-11,200
-38% -$748K 0.05% 358
2021
Q1
$1.9M Buy
+29,400
New +$1.9M 0.09% 231
2020
Q4
Sell
-39,200
Closed -$2.46M 672
2020
Q3
$2.46M Buy
39,200
+7,600
+24% +$527K 0.2% 112
2020
Q2
$2.43M Buy
+31,600
New +$2.42M 0.17% 110
2020
Q1
Sell
-29,300
Closed -$1.89M 360
2019
Q4
$1.89M Buy
+29,300
New +$1.91M 0.17% 110

Other funds holding GILD

Maven Securities's GILD Position: Q2 2025 in Review

Maven Securities sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 4,983 shares — an estimated $530K sold.

Maven Securities first reported a position in GILD in Q4 2016 and held it in 8 quarters. The position peaked at $1.18M in Q4 2020. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Maven Securities reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 4,983 Gilead Sciences shares in Q2 2025, an estimated $530K.
  • Maven Securities first reported a position in Gilead Sciences in Q4 2016 and held it in 8 quarters.
  • Maven Securities's Gilead Sciences position peaked at $1.18M in Q4 2020.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.